Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
Go back to Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress| (NASDAQ: HELP) | Delayed: 5.09 +0.24 (4.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $ | |||
| Open | $5.20 | 52 Week Low | $ | |||
| Day High | $5.40 | P/E | N/A | |||
| Day Low | $4.96 | EPS | $ | |||
| Volume | 3,211,323 | |||||
